Loading…
Adept Life Science, LLC received a warning letter for serious Current Good Manufacturing Practice (CGMP) violations in its dietary supplement manufacturing operations at its Chandler, Arizona facility, inspected in April 2022. The company failed to establish identity specifications for raw materials used in its dietary supplement products and did not meet CGMP requirements for manufacturing, packaging, labeling, and holding operations, rendering the products adulterated under federal law. Additionally, certain dietary supplement product lines were found to be misbranded in violation of FDA regulations. The company's responses to FDA's initial inspection observations were incomplete, failing to adequately address all cited violations.